Pentwater Capital Management LP Karuna Therapeutics, Inc. Transaction History

Pentwater Capital Management LP

$9.58 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$161.01 - $317.85 $167 Million - $330 Million	1,037,700 Added 3641.05%	1,066,200 $337 Million
Q3 2023 Nov 14, 2023	BUY	$164.66 - $218.08 $246,990 - $327,120	1,500 Added 5.56%	28,500 $4.82 Million
Q2 2023 Aug 14, 2023	SELL	$176.32 - $240.22 $3.7 Million - $5.04 Million	-21,000 Reduced 43.75%	27,000 $5.85 Million
Q1 2023 May 15, 2023	BUY	$161.33 - $204.36 $6.13 Million - $7.77 Million	38,000 Added 380.0%	48,000 $8.72 Million
Q4 2022 Feb 14, 2023	BUY	$191.53 - $236.82 $670,355 - $828,870	3,500 Added 53.85%	10,000 $1.97 Million
Q3 2022 Nov 14, 2022	SELL	$123.79 - $277.42 $2.91 Million - $6.52 Million	-23,500 Reduced 78.33%	6,500 $1.46 Million
Q2 2022 Aug 15, 2022	SELL	$93.97 - $143.33 $939,700 - $1.43 Million	-10,000 Reduced 25.0%	30,000 $3.8 Million
Q1 2022 May 16, 2022	SELL	$98.9 - $132.37 $1.98 Million - $2.65 Million	-20,000 Reduced 33.33%	40,000 $5.07 Million
Q4 2021 Feb 11, 2022	SELL	$110.64 - $159.4 $907,248 - $1.31 Million	-8,200 Reduced 12.02%	60,000 $7.86 Million
Q1 2021 May 17, 2021	BUY	$95.46 - $133.08 $782,772 - $1.09 Million	8,200 Added 13.67%	68,200 $8.2 Million
Q4 2020 Feb 16, 2021	SELL	$75.23 - $109.23 $752,300 - $1.09 Million	-10,000 Reduced 14.29%	60,000 $6.1 Million
Q3 2020 Nov 16, 2020	BUY	$71.31 - $109.74 $1.64 Million - $2.52 Million	23,000 Added 48.94%	70,000 $5.41 Million
Q2 2020 Aug 14, 2020	SELL	$62.14 - $117.21 $585,172 - $1.1 Million	-9,417 Reduced 16.69%	47,000 $5.24 Million
Q1 2020 May 15, 2020	SELL	$60.41 - $115.92 $92,668 - $177,821	-1,534 Reduced 2.65%	56,417 $4.06 Million
Q4 2019 Feb 14, 2020	SELL	$11.44 - $123.99 $51,468 - $557,831	-4,499 Reduced 7.2%	57,951 $4.37 Million
Q3 2019 Nov 14, 2019	SELL	$16.05 - $27.35 $121,177 - $206,492	-7,550 Reduced 10.79%	62,450 $1.02 Million
Q2 2019 Aug 14, 2019	BUY	$20.02 - $20.02 $1.4 Million - $1.4 Million	70,000 New	70,000 $1.4 Million

Others Institutions Holding KRTX

# of Institutions

Shares Held

332K

Call Options Held

Put Options Held

View Full List

About Karuna Therapeutics, Inc.

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

More about KRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pentwater Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Pentwater Capital Management LP with notifications on news.

Account